BioSpace News Archive

Agenus today announced the launch of a subsidiary company for its cell therapy business, AgenTus Therapeutics.

Clovis Oncology, Inc. will announce its third quarter 2017 financial results on Wednesday, November 1, 2017, after the close of the U.S. financial markets.

Arrowhead Pharmaceuticals today presented data from studies demonstrating promising preclinical safety and efficacy of ARO-AAT.

NuVasivetive today announced new lateral solutions that enable surgeons to perform lateral single-position surgery and expand the Company’s comprehensive lateral portfolio.

Boehringer Ingelheim announced today the presentation of a new analysis on the use of Ofev (nintedanib) in treating people with idiopathic pulmonary fibrosis (IPF) at the 2017 CHEST Annual Meeting.

EMD Serono today announced the appointment of Robert Truckenmiller as Senior VP, Market Access & Customer Solutions.

Tolero Pharma today announced preclinical data supporting development of TP-1287 and TP-3654 in triple negative breast cancer. [23-October-2017] SALT LAKE CITY, Oct. 23, 2017 /PRNewswire/ -- Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing treatments for hematological diseases, today announced preclinical data supporting developm

Data from the trial are expected to be communicated before the end of 2017.

A live webcast will be available in the Media Center of the Progenics website.

The new facility will expand Kraig Labs’ research and production programs.